Hotline:
+ 49 (0) 2204 2918806

Market studies for category Oncology/Hematology

Items 1 to 10 of 2139 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 214
  1. Net price*
    Year
  2. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Plague – Pipeline Review, H2 2012

    Global Markets Direct
    59 pages
    Introduction Global Markets Direct’s, 'Plague - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Plague, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players in
    Englisch | Report | SKU: 318277
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Other Dermatological Disorders – Pipeline Review, H1 2013

    Global Markets Direct
    41 pages
    Introduction Global Markets Direct’s, 'Other Dermatological Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Dermatological Disorders, complete with latest updates, and special features on late-stage and disco
    Englisch | Report | SKU: 324423
  4. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Hematological Tumor Global Clinical Trials Review, H1, 2015

    GlobalData
    102 pages
    GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H1, 2015" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment
    Englisch | Zukunftsanalyse | SKU: 987679992
  5. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Blepharitis – Pipeline Review, H2 2012

    Global Markets Direct
    40 pages
    Introduction Global Markets Direct’s, 'Blepharitis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Blepharitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Report | SKU: 317989
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Osteoarthritis Pain – Pipeline Review, H1 2013

    Global Markets Direct
    127 pages
    Introduction Global Markets Direct’s, 'Osteoarthritis Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis Pain, complete with latest updates, and special features on late-stage and discontinued projects. It a
    Englisch | Report | SKU: 318629
  7. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2014

    Global Markets Direct
    50 pages
    Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2014’, provides an overview of the Thrombotic Thrombocytopenic Purpura’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thrombotic Thrombocytopenic Purpura, complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 394151
  8. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Bausch & Lomb Incorporated – Product Pipeline Review – 2012

    Global Markets Direct
    126 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Bausch & Lomb Incorporated - Product Pipeline Review - 2012” provides data on the Bausch & Lomb Incorporated’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued an
    Englisch | Product Pipeline Review | SKU: 317701
  9. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Trauma – Pipeline Review, H2 2012

    Global Markets Direct
    47 pages
    Introduction Global Markets Direct’s, 'Trauma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Trauma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players in
    Englisch | Report | SKU: 318341
  10. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Mild Cognitive Impairment – Pipeline Review, H1 2013

    Global Markets Direct
    91 pages
    Introduction Global Markets Direct’s, 'Mild Cognitive Impairment - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Mild Cognitive Impairment, complete with latest updates, and special features on late-stage and discontinued pr
    Englisch | Report | SKU: 324487
  11. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Refractory Leukemia - Pipeline Review, H1 2015

    Global Markets Direct
    41 pages
    Global Markets Direct’s, ‘Refractory Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Leukemia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Refractory Leukemia, complete with comparative analysis at various stages, therapeutics assessment by dr
    Englisch | Zukunftsanalyse | SKU: 987688409

Items 1 to 10 of 2139 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 214